University of Florida

COVID-19 - A clinical update

Access provided by Coursera Learning Team

23,886 already enrolled

Gain insight into a topic and learn the fundamentals.
4.7

(342 reviews)

Intermediate level

Recommended experience

Flexible schedule
Approx. 5 hours
Learn at your own pace
96%
Most learners liked this course
Gain insight into a topic and learn the fundamentals.
4.7

(342 reviews)

Intermediate level

Recommended experience

Flexible schedule
Approx. 5 hours
Learn at your own pace
96%
Most learners liked this course

What you'll learn

  • Understand how this coronavirus invades respiratory epithelial cells, grows in the nasal passages and spreads to alveoli to cause hypoxia.

  • Describe what makes this coronavirus so infectious, how it has spread quickly throughout the world and how best to stop its spread.

  • Recognize the clinical symptoms of COVID-19 disease and be able to diagnose this disease

  • List the recommended treatments for COVD-19, as well as the treatments under investigation

Skills you'll gain

Details to know

Shareable certificate

Add to your LinkedIn profile

Assessments

2 assignments

Taught in English
Placeholder

Earn a career certificate

Add this credential to your LinkedIn profile, resume, or CV

Share it on social media and in your performance review

Placeholder

There are 2 modules in this course

Coronaviruses infect many species of animal including the bat. These RNA viruses frequently mutate particularly in bats, and chance mutations rendered the SARS-CoV-2 capable of readily infecting humans. The bat virus infected an intermediate host, possibly the Pangolin that was sold in the live fish and animal market in China. A key virulence (characteristic that allows a pathogen to cause disease) factor is the S protein which was the likely primary target of the mutations. This protein forms knobs on the outer surface of the virus that bind strongly to the ACE2 receptor on human respiratory epithelial cells. Binding is followed by internalization and within the cell the virus replicates its RNA using a replicase and assembles into a nuclear capsid in the host cell cytoplasm RNA is also translated into proteins that coat the outer surface of the virus. Once fully assembled the virus is exocytosed (released) from vesicles. The new viral particles can infect other cells and spread to other humans. Because of the inaccuracy of the viral replicase as the virus actively grows it produces point mutations. Some of these mutant virus more effectively infect cells. The alpha variant became prominent in the Winter and Spring of 2021 subsequently a more highly infectious variant the Delta variant that originated in India dominated and now a third variant, omicron that originated in South Africa is now spreading throughout the world and quickly dominating in Europe and the U.S. The virus first replicates in the throat and nasal passages and then spreads to the trachea, bronchi and alveoli where it induces inflammation and damage to the alveolar walls causing fluid to leak into the air exchanging sacks and interfering with oxygen exchange. If inflammation continues the alveolar walls become fibrosed (scarred) and further compromising oxygen exchange resulting in decreases in oxygen saturation (hypoxia). SARS-CoV-2 is able to spread efficiently from person to person primarily by droplets and aerosol (tiny particles that stay in the air for hours). Infection quickly spread throughout the world and caused a pandemic within 3 months. Humans were infected at the Huanan live fish and animal market. The infection initially was confined to workers in the market (point source) but then quickly spread person to person within the first 10 days. Because of the lack of travel restrictions early in the outbreak Chinese traveling from the area quickly spread the virus to many other countries. In the early phases lack of therapy or vaccine allowed the virus to move from person to person unchecked with a steep exponential curve with a doubling of cases every 2-3 days. This virus is one of the most infectious ever reported each infected person on average infecting 2.0 to 2.7 people, the alpha variant can infect 3.0-5.0, the Delta variant one person on average infects 5-8 individuals and the omicron 10-16. The last two variants can cause breakthrough infections in vaccinated individuals. Another characteristic that has allowed rapid spread is the existence of 40-60% asymptomatic or minimally symptomatic carriers. 10% are superspreaders infecting on average 10-80 others.

What's included

5 videos2 readings1 assignment1 peer review

COVID-19 presents similarly to influenza. The most common symptoms are fever (>100.4 °F or 38°C), dry cough, and shortness of breath. Other common symptoms include marked fatigue, myalgias (muscle aches), headache, and sorethroat. Chest tightness can develop early in severe cases. Diarrhea and vomiting less commonly can be presenting complaints. Physical exam is usually unremarkable with the exception of fever, tachycardias (elevated pulse), an elevated respiratory rate and low oxygen saturation on room air. Lymphadenopathy is usually not present and pulmonary exam is unremarkable. Laboratory studies are nonspecific with a low lymphocyte count, low platelets, elevated CRP, and normal procalcitonin level. CXR is insensitive (60% sensitivity) chest CT being more sensitive and highly specific and is the study of choice in patients being considered for admission to the hospital. Treatment consists of supportive care by administering nasal O2 to maintain saturation above 92%. If nasal O2 fails to achieve appropriate oxygenation intubation and mechanical ventilation with PEEP (positive end expiratory pressure) is recommended and standard ARDS protocols should guide care. Septic shock with end organ damage can develop and standard sepsis protocols are recommended with the exception of fluid administration which should be cautious.

What's included

6 videos1 reading1 assignment

Instructor

Instructor ratings
4.8 (112 ratings)
Frederick S. Southwick, MD
University of Florida
3 Courses41,745 learners

Offered by

Why people choose Coursera for their career

Felipe M.
Learner since 2018
"To be able to take courses at my own pace and rhythm has been an amazing experience. I can learn whenever it fits my schedule and mood."
Jennifer J.
Learner since 2020
"I directly applied the concepts and skills I learned from my courses to an exciting new project at work."
Larry W.
Learner since 2021
"When I need courses on topics that my university doesn't offer, Coursera is one of the best places to go."
Chaitanya A.
"Learning isn't just about being better at your job: it's so much more than that. Coursera allows me to learn without limits."

Learner reviews

4.7

342 reviews

  • 5 stars

    78.36%

  • 4 stars

    16.66%

  • 3 stars

    2.33%

  • 2 stars

    0.58%

  • 1 star

    2.04%

Showing 3 of 342

JN
5

Reviewed on Jun 21, 2020

SN
4

Reviewed on Jun 13, 2020

HB
5

Reviewed on Apr 20, 2020

Recommended if you're interested in Health

Placeholder

Open new doors with Coursera Plus

Unlimited access to 10,000+ world-class courses, hands-on projects, and job-ready certificate programs - all included in your subscription

Advance your career with an online degree

Earn a degree from world-class universities - 100% online

Join over 3,400 global companies that choose Coursera for Business

Upskill your employees to excel in the digital economy